Department of Health and Human Services
National Institutes of Health
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel. Fellowship Review.
Date: November 29, 2005.
Time: 8 a.m. to 5 p.m. ( printed page 69581)
Agenda: To review and evaluate grant applications.
Place: Willard Hotel, 1401 Pennsylvania Avenue, Washington, DC 20004.
Contact Person: Joann McConnell, PhD., Scientific Review Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892-9529. (301) 496-5324. mcconnej@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel. Cell Biology of Parkinson's Disease.
Date: December 1, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Four Points Sheraton BWI, 7032 Elm Road, Baltimore, MD 21240.
Contact Person: Shantadurga Rajaram, PhD, Scientific Review Administrator, Scientific Review Branch NIH/NINDS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20852. (301) 435-6033. rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)
Dated: November 4, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.